Tag Archives: Used

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?

February 07, 2019 Share this content: Improvements in 6-minute walking distance scores and WHO functional class categories were seen in patients with PAH treated with macitentan plus riociguat. Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension (PAH), according to the results of a small retrospective, open-label cohort… Read More »